Plasma supply normalisation taking longer than expected
04/12/21 -"The recent surge of the more-contagious Omicron variant could result in delayed recovery for plasma supplies. Remember, with various preliminary studies signalling limited protection from currently ..."
Pages
61
Language
English
Published on
04/12/21
You may also be interested by these reports :
08/05/24
Sandoz is moving ahead well with two crucial aspects of its medium-term sales and profitability goals: 1/ a strong performance from Biosimilars and ...
07/05/24
Q1 sales missed the consensus estimates, although the CER growth was largely in line with the firm’s full-year outlook. Biosimilars were the main ...
03/05/24
Genmab’s Q1 sales exceeded expectations, although profitability fell somewhat short. This robust performance was led by strong growth across all the ...
03/05/24
We have rolled forward our model to include a new forecast year (2026) which will also see continued healthy top-line growth and profitability ...